PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Canadian Journal of Emergency Medicine

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Canadian Journal of Emergency Medicine has 1 tracked paper indexed in Blossom (2026) from 10 authors, most often covering Ketamine, across Depressive Disorders and Suicidality.

Published Papers

Paywallindividual

A pilot randomized trial of ketamine for suicidal ideation in a pediatric emergency department

This triple-blind randomised controlled trial (n=15) in adolescents with suicidal ideation in a paediatric emergency department tested whether intravenous ketamine, midazolam or saline could be studied feasibly and safely. Recruitment and follow-up were good, blinding seemed effective, and no serious or unexpected adverse events occurred.

Published
June 3, 2026
Journal
Canadian Journal of Emergency Medicine
Authors
Onikashvili, Y., Burt, H., Meckler, G., Bone, J. N., Hind, T., Sih, K., Sassi, R., Stillwell, K., Black, T., Doan, Q.

Quick Facts

Papers Indexed
1
h-Index
60
Open Access
No
Publisher
Springer Nature
Country
Germany
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.